Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_provenance.
- NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_assertion description "[The TOV-21G, TOV-81D, OV-90, and TOV-112D cell lines were derived from ovarian tumors (TOV) or ascites (OV) from chemotherapy- and radiotherapy-naive patients and were characterized by their mutation spectrum of BRCA2, TGFbeta-RII, KRAS2, TP53, and CDKN2A.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_provenance.
- NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_assertion evidence source_evidence_literature NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_provenance.
- NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_assertion SIO_000772 15258697 NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_provenance.
- NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_assertion wasDerivedFrom befree-20150227 NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_provenance.
- NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_assertion wasGeneratedBy ECO_0000203 NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP306758.RARx85xUpfXgMZj1S69pBHI0kcyeIMhgXlqMhUxX9UXsE130_provenance.